Narrative Review of the Role of Nondepolarizing Neuromuscular Blocking Agents in Anesthesia: Perspective 2026
Medical Science Monitor · 2026
DOI: 10.12659/msm.951845 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Science Monitor, 2026. Verfasst von Paweł Radkowski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care, Faculty of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland. Hauptthemen laut MEDLINE: Neuromuscular Blocking Agents, Anesthesia, Neuromuscular Nondepolarizing Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In this narrative review, we summarize the current state of knowledge on novel isoquinolinium chlorofumarate diesters and pinnatoxins as potential neuromuscular blocking agents for modern anesthesia. Isoquinolinium derivatives gantacurium, CW002, CW011, and CW1759-50 are discussed due to promising initial findings, with animal and human studies presented to assess which agent may have the greatest potential for future clinical use. The approval process for gantacurium has reached Phase III clinical trials, but further trials are no longer ongoing. CW002 has undergone animal and human testing, and early results suggest fewer cardiovascular and pulmonary adverse effects; however, CW002 produces a longer neuromuscular block and is more difficult to antagonize than gantacurium. CW011 and CW1759-50 have been tested only in animal models. We also describe agents used to reverse neuromuscular block. L-cysteine is an amino acid that reverses the described fumarate-based neuromuscular blocking agents by reacting with the carbon-carbon double bond to form a stable thioether adduct that cannot bind to acetylcholine receptors. This adduct then slowly hydrolyses into inactive fragments, enabling rapid and complete reversal. Calabadion binds aminosteroid and benzylisoquinoline neuromuscular blockers by forming "host-guest" complexes, rapidly binding free relaxant molecules in plasma and acting faster than sugammadex, making it a potentially promising reversal agent. This article aims to review the role of nondepolarizing neuromuscular blocking agents in anesthesia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care, Faculty of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.
- Clinical Department of Anesthesiology and Intensive Care, Regional Specialist Hospital, Olsztyn, Poland.
- Klinika-Hospital Zum Heiligen Geist, Fritzlar, Germany.
- University Clinical Hospital in Białystok, Białystok, Poland.
- Medical University of Białystok, Białystok, Poland.
- Department of Anesthesiology and Intensive Care, Ceynowa Specialist Hospital, Wejherowo, Poland.
ORCID-Profile: Paweł Radkowski, Adam Rafałowicz, Marcin Muża, Karolina Marczuk, Mateusz Mamala, Łukasz Grabarczyk
Zitieren
APA
Radkowski, P., Rafałowicz, A., Wojciechowka, U. J., Muża, M., Marczuk, K., Mamala, M., & Grabarczyk, Ł. (2026). Narrative Review of the Role of Nondepolarizing Neuromuscular Blocking Agents in Anesthesia: Perspective 2026. Medical Science Monitor. https://doi.org/10.12659/msm.951845
Vancouver
Radkowski P, Rafałowicz A, Wojciechowka UJ, Muża M, Marczuk K, Mamala M, et al. Narrative Review of the Role of Nondepolarizing Neuromuscular Blocking Agents in Anesthesia: Perspective 2026. Medical Science Monitor. 2026. doi:10.12659/msm.951845
BibTeX
@article{Radkowski2026,
author = {Radkowski, Paweł and Rafałowicz, Adam and Wojciechowka, Urszula Justyna and Muża, Marcin and Marczuk, Karolina and Mamala, Mateusz and Grabarczyk, Łukasz},
title = {Narrative Review of the Role of Nondepolarizing Neuromuscular Blocking Agents in Anesthesia: Perspective 2026},
journal = {Medical Science Monitor},
year = {2026},
doi = {10.12659/msm.951845}
}
EUVIMED